Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial

US Innovation Foundation director sells $1.6M Linkhome shares privately

Investing.com · News 29m ago

Odd Lots: How to Run a Restaurant For Three Decades (Podcast)

Bloomberg · Markets 30m ago

The Next AI Infrastructure Winner Isn't a Memory Stock. It's This.

NASDAQ · Markets 40m ago

Indonesia Begins Trimming Pipeline Gas Exports to Singapore

Bloomberg · Markets 41m ago

Asana CEO Daniel Rogers sells $226,596 of ASAN shares

Investing.com · News 44m ago

UK to inject £20.4 billion into state-backed lenders in budget, FT reports

Investing.com · News 55m ago

Winmark COO Renae Gaudette sells $531,519 in stock

Investing.com · News 59m ago

Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem

NASDAQ · Markets 1h ago

Martine Rothblatt, United Therapeutics CEO, sells $5.5M in stock

Investing.com · News 1h ago

Robinhood director Baiju Bhatt sells $5.16M HOOD shares

Investing.com · News 1h ago